• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤相关巨噬细胞(TAMs)在结直肠癌中的抗肿瘤作用依赖于Shp2。

Tumor-associated macrophages (TAMs) depend on Shp2 for their anti-tumor roles in colorectal cancer.

作者信息

Wang Saisai, Yao Yuanyuan, Li Huixia, Zheng Gang, Lu Sen, Chen Wenbin

机构信息

Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, P. R. China.

Department of Colorectal Surgery, The Central Hospital of Lishui City Lishui, P. R. China.

出版信息

Am J Cancer Res. 2019 Sep 1;9(9):1957-1969. eCollection 2019.

PMID:31598397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6780667/
Abstract

Tumor associated macrophages (TAMs) in tumor microenvironment can interact with tumor cells and are related to tumor progression. However, the mechanisms that drive the anti-tumor functions of TAMs are not fully understood. The Src homology 2 domain-containing tyrosine phosphatase 2 (Shp2) has been reported to have tumor-suppressing roles in colorectal cancer (CRC). However, a role for Shp2 on TAMs in CRC has not been studied. Here we report that in CRC, Shp2 expression on TAMs is negatively associated with liver metastasis. TAMs require Shp2 for their anti-tumor functions in a cell-cell co-culture system and a mouse model of CRC. Mechanistically, absence of Shp2 on TAMs induces their polarization toward M2 phenotype through the activation of p-STAT3 and inhibition of p-NF-κB p65. The findings of our study imply that Shp2 is a key factor in the tumor microenvironment to facilitate the TAMs' tumor-suppressing functions in colorectal cancer.

摘要

肿瘤微环境中的肿瘤相关巨噬细胞(TAM)可与肿瘤细胞相互作用,并与肿瘤进展相关。然而,驱动TAM发挥抗肿瘤功能的机制尚未完全明确。据报道,含Src同源2结构域的酪氨酸磷酸酶2(Shp2)在结直肠癌(CRC)中具有肿瘤抑制作用。然而,Shp2在CRC的TAM中的作用尚未得到研究。在此我们报告,在CRC中,TAM上的Shp2表达与肝转移呈负相关。在细胞-细胞共培养系统和CRC小鼠模型中,TAM发挥抗肿瘤功能需要Shp2。机制上,TAM上缺乏Shp2会通过激活p-STAT3和抑制p-NF-κB p65诱导其向M2表型极化。我们的研究结果表明,Shp2是肿瘤微环境中促进TAM在结直肠癌中发挥肿瘤抑制功能的关键因素。

相似文献

1
Tumor-associated macrophages (TAMs) depend on Shp2 for their anti-tumor roles in colorectal cancer.肿瘤相关巨噬细胞(TAMs)在结直肠癌中的抗肿瘤作用依赖于Shp2。
Am J Cancer Res. 2019 Sep 1;9(9):1957-1969. eCollection 2019.
2
Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.Wnt5a 通过 IL-10 诱导肿瘤相关巨噬细胞向 M2 极化促进结直肠癌进展。
Cell Commun Signal. 2020 Mar 30;18(1):51. doi: 10.1186/s12964-020-00557-2.
3
Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.癌细胞与肿瘤相关巨噬细胞之间的串扰对于间质循环肿瘤细胞介导的结直肠癌转移是必需的。
Mol Cancer. 2019 Mar 30;18(1):64. doi: 10.1186/s12943-019-0976-4.
4
Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer.肿瘤相关巨噬细胞特异性 CD155 促进结直肠癌中 M2 表型转化、免疫抑制和肿瘤进展。
J Immunother Cancer. 2022 Sep;10(9). doi: 10.1136/jitc-2021-004219.
5
Gab2 promotes the growth of colorectal cancer by regulating the M2 polarization of tumor‑associated macrophages.Gab2 通过调控肿瘤相关巨噬细胞的 M2 极化促进结直肠癌的生长。
Int J Mol Med. 2024 Jan;53(1). doi: 10.3892/ijmm.2023.5327. Epub 2023 Nov 8.
6
M-CSF secreted by gastric cancer cells exacerbates the progression of gastric cancer by increasing the expression of SHP2 in tumor-associated macrophages.胃癌细胞分泌的 M-CSF 通过增加肿瘤相关巨噬细胞中 SHP2 的表达来加剧胃癌的进展。
Aging (Albany NY). 2023 Dec 29;15(24):15525-15534. doi: 10.18632/aging.205390.
7
α7 nicotinic acetylcholine receptor in tumor-associated macrophages inhibits colorectal cancer metastasis through the JAK2/STAT3 signaling pathway.肿瘤相关巨噬细胞中的α7 型烟碱型乙酰胆碱受体通过 JAK2/STAT3 信号通路抑制结直肠癌细胞转移。
Oncol Rep. 2017 Nov;38(5):2619-2628. doi: 10.3892/or.2017.5935. Epub 2017 Sep 4.
8
Astragaloside IV inhibits colorectal cancer metastasis by reducing extracellular vesicles release and suppressing M2-type TAMs activation.黄芪甲苷IV通过减少细胞外囊泡释放和抑制M2型肿瘤相关巨噬细胞激活来抑制结直肠癌转移。
Heliyon. 2024 May 22;10(10):e31450. doi: 10.1016/j.heliyon.2024.e31450. eCollection 2024 May 30.
9
FAM198B promotes colorectal cancer progression by regulating the polarization of tumor-associated macrophages via the SMAD2 signaling pathway.FAM198B 通过调控 SMAD2 信号通路促进肿瘤相关巨噬细胞的极化进而促进结直肠癌的进展。
Bioengineered. 2022 May;13(5):12435-12445. doi: 10.1080/21655979.2022.2075300.
10
Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene.MUC1对巨噬细胞极化和肺癌细胞干性的调节作用及相关小分子抑制剂紫檀芪的研发
Oncotarget. 2016 Jun 28;7(26):39363-39375. doi: 10.18632/oncotarget.8101.

引用本文的文献

1
Targeting SHP2: Dual breakthroughs in colorectal cancer therapy-from signaling pathway modulation to immune microenvironment remodeling.靶向SHP2:结直肠癌治疗的双重突破——从信号通路调节到免疫微环境重塑
World J Gastrointest Oncol. 2025 Jul 15;17(7):107380. doi: 10.4251/wjgo.v17.i7.107380.
2
Biological Roles and Clinical Therapeutic Applications of Tumor-Associated Macrophages in Colorectal Liver Metastasis.肿瘤相关巨噬细胞在结直肠癌肝转移中的生物学作用及临床治疗应用
J Inflamm Res. 2024 Nov 7;17:8429-8443. doi: 10.2147/JIR.S493656. eCollection 2024.
3
CCL2 mediated IKZF1 expression promotes M2 polarization of glioma-associated macrophages through CD84-SHP2 pathway.CCL2 介导的 IKZF1 表达通过 CD84-SHP2 通路促进胶质瘤相关巨噬细胞的 M2 极化。
Oncogene. 2024 Aug;43(36):2737-2749. doi: 10.1038/s41388-024-03118-w. Epub 2024 Aug 7.
4
SHP2 mediates STAT3/STAT6 signaling pathway in TAM to inhibit proliferation and metastasis of lung adenocarcinoma.SHP2 介导 TAM 中的 STAT3/STAT6 信号通路抑制肺腺癌的增殖和转移。
Aging (Albany NY). 2024 May 14;16(18):12498-12509. doi: 10.18632/aging.205799.
5
NanoSHP099-Targeted SHP2 Inhibition Boosts Ly6C Monocytes/Macrophages Differentiation to Accelerate Thrombolysis.NanoSHP099 靶向 SHP2 抑制增强 Ly6C 单核细胞/巨噬细胞分化以加速溶栓。
Adv Sci (Weinh). 2024 Apr;11(13):e2308166. doi: 10.1002/advs.202308166. Epub 2024 Jan 21.
6
Protein tyrosine phosphatases as emerging targets for cancer immunotherapy.蛋白酪氨酸磷酸酶作为癌症免疫治疗的新兴靶点。
Br J Pharmacol. 2023 Dec 20. doi: 10.1111/bph.16304.
7
Macrophage-derived SHP-2 inhibits the metastasis of colorectal cancer via Tie2-PI3K signals.巨噬细胞衍生的 SHP-2 通过 Tie2-PI3K 信号抑制结直肠癌转移。
Oncol Res. 2023 Apr 10;31(2):125-139. doi: 10.32604/or.2023.028657. eCollection 2023.
8
Protein phosphatases regulate the liver microenvironment in the development of hepatocellular carcinoma.蛋白磷酸酶调控肝癌发生发展中的肝微环境。
Exp Mol Med. 2022 Nov;54(11):1799-1813. doi: 10.1038/s12276-022-00883-0. Epub 2022 Nov 15.
9
A pan-cancer analysis confirms PTPN11's potential as a prognostic and immunological biomarker.泛癌分析证实 PTPN11 有作为预后和免疫生物标志物的潜力。
Aging (Albany NY). 2022 Jul 8;14(13):5590-5610. doi: 10.18632/aging.204171.
10
Functional and Therapeutic Significance of Tumor-Associated Macrophages in Colorectal Cancer.肿瘤相关巨噬细胞在结直肠癌中的功能及治疗意义
Front Oncol. 2022 Feb 2;12:781233. doi: 10.3389/fonc.2022.781233. eCollection 2022.

本文引用的文献

1
Phosphatase Shp2 exacerbates intestinal inflammation by disrupting macrophage responsiveness to interleukin-10.磷酸酶 Shp2 通过破坏巨噬细胞对白细胞介素-10 的反应性来加重肠道炎症。
J Exp Med. 2019 Feb 4;216(2):337-349. doi: 10.1084/jem.20181198. Epub 2019 Jan 4.
2
TGF-β secreted by tumor-associated macrophages promotes proliferation and invasion of colorectal cancer via miR-34a-VEGF axis.肿瘤相关巨噬细胞分泌的 TGF-β 通过 miR-34a-VEGF 轴促进结直肠癌细胞的增殖和侵袭。
Cell Cycle. 2018;17(24):2766-2778. doi: 10.1080/15384101.2018.1556064. Epub 2018 Dec 20.
3
Targeting macrophages: therapeutic approaches in cancer.靶向巨噬细胞:癌症的治疗方法。
Nat Rev Drug Discov. 2018 Dec;17(12):887-904. doi: 10.1038/nrd.2018.169. Epub 2018 Oct 26.
4
Coagulation Factor X Regulated by CASC2c Recruited Macrophages and Induced M2 Polarization in Glioblastoma Multiforme.由CASC2c调控的凝血因子X招募巨噬细胞并诱导多形性胶质母细胞瘤中的M2极化。
Front Immunol. 2018 Jul 6;9:1557. doi: 10.3389/fimmu.2018.01557. eCollection 2018.
5
Role of protein phosphatases in the cancer microenvironment.蛋白质磷酸酶在癌症微环境中的作用。
Biochim Biophys Acta Mol Cell Res. 2019 Jan;1866(1):144-152. doi: 10.1016/j.bbamcr.2018.07.006. Epub 2018 Jul 17.
6
Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?靶向 SHP-1、2 和 SHIP 通路:癌症治疗的新策略?
Oncology. 2018;95(5):257-269. doi: 10.1159/000490106. Epub 2018 Jun 20.
7
Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis.酪氨酸磷酸酶 SHP2 通过依赖于 ANT1 的线粒体稳态负调控 NLRP3 炎性体激活。
Nat Commun. 2017 Dec 18;8(1):2168. doi: 10.1038/s41467-017-02351-0.
8
SHP2 associates with nuclear localization of STAT3: significance in progression and prognosis of colorectal cancer.SHP2 与 STAT3 的核定位相关:在结直肠癌的进展和预后中的意义。
Sci Rep. 2017 Dec 14;7(1):17597. doi: 10.1038/s41598-017-17604-7.
9
T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice.T淋巴细胞SHP2缺陷引发抗肿瘤免疫,抑制小鼠结肠炎相关癌症。
Oncotarget. 2017 Jan 31;8(5):7586-7597. doi: 10.18632/oncotarget.13812.
10
Tumor-associated stromal cells as key contributors to the tumor microenvironment.肿瘤相关基质细胞是肿瘤微环境的关键促成因素。
Breast Cancer Res. 2016 Aug 11;18(1):84. doi: 10.1186/s13058-016-0740-2.